Stock Research for ENTA

ENTA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ENTA Stock Chart & Research Data

The ENTA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ENTA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ENTA Due diligence Resources & Stock Charts

The ENTA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ENTA Detailed Price Forecast - CNN Money CNN View ENTA Detailed Summary - Google Finance
Yahoo View ENTA Detailed Summary - Yahoo! Finance Zacks View ENTA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ENTA Trends & Analysis - Trade-Ideas Barrons View ENTA Major Holders - Barrons
NASDAQ View ENTA Call Transcripts - NASDAQ Seeking View ENTA Breaking News & Analysis - Seeking Alpha
Spotlight View ENTA Annual Report - CompanySpotlight.com OTC Report View ENTA OTC Short Report - OTCShortReport.com
TradeKing View ENTA Fundamentals - TradeKing Charts View ENTA SEC Filings - Bar Chart
WSJ View Historical Prices for ENTA - The WSJ Morningstar View Performance/Total Return for ENTA - Morningstar
MarketWatch View the Analyst Estimates for ENTA - MarketWatch CNBC View the Earnings History for ENTA - CNBC
StockMarketWatch View the ENTA Earnings - StockMarketWatch MacroAxis View ENTA Buy or Sell Recommendations - MacroAxis
Bullish View the ENTA Bullish Patterns - American Bulls Short Pains View ENTA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ENTA Stock Mentions - StockTwits PennyStocks View ENTA Stock Mentions - PennyStockTweets
Twitter View ENTA Stock Mentions - Twitter Invest Hub View ENTA Investment Forum News - Investor Hub
Yahoo View ENTA Stock Mentions - Yahoo! Message Board Seeking Alpha View ENTA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ENTA - SECform4.com Insider Cow View Insider Transactions for ENTA - Insider Cow
CNBC View ENTA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ENTA - OTC Markets
Yahoo View Insider Transactions for ENTA - Yahoo! Finance NASDAQ View Institutional Holdings for ENTA - NASDAQ


Stock Charts

FinViz View ENTA Stock Insight & Charts - FinViz.com StockCharts View ENTA Investment Charts - StockCharts.com
BarChart View ENTA Stock Overview & Charts - BarChart Trading View View ENTA User Generated Charts - Trading View




Latest Financial News for ENTA


Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Posted on Wednesday April 17, 2024

WATERTOWN, Mass., April 17, 2024--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for indications in virology and immunology, today announced that data from the company’s SPRINT (SARS-Cov-2 PRotease INhibitor Treatment) study of EDP-235 has been accepted for a poster presentation at ESCMID Global 2024 (formerly ECCMID) being held April 27–30 in Barcelona, Spain.


Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
Posted on Wednesday March 06, 2024

WATERTOWN, Mass., March 06, 2024--Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for indications in virology and immunology, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strategy Officer, will participate in a fireside chat at Leerink Partners Global Biopharma Conference on March 13, 2024 at 10:40 a.m. ET in Miami, FL.


Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Posted on Monday February 12, 2024

The analysts might have been a bit too bullish on Enanta Pharmaceuticals, Inc. ( NASDAQ:ENTA ), given that the company...


Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
Posted on Thursday February 08, 2024

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript February 7, 2024 Enanta Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to Enanta Pharmaceuticals’ Fiscal First Quarter Financial Results Conference Call. At this time, […]


Stock Market & Investing Books

Enter a stock symbol to view the stock details.